Ailesel Akdeniz Ateşi

Barron K, Kastner DL. Periodic fever syndromes and other inherited autoinflammatory diseases. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC (eds). Textbook of Pediatric Rheumatology.Eighth edition, Elsevier, Philadelphia, 2021: 525-543.

Ben-Chetrit E. https://www.uptodate.com/contents/familial-mediterranean-fever-epidemiology-genetics-and-pathogenesis?search

Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine, 1998; 77(4): 268-297.

Van Gorp H, Huang L, Saavedra P, Vuylsteke M, Asaoka T, Prencipe G et al. Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever. Ann Rheum Dis, 2020; 79: 960-968.

Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet, 2001; 9: 473-483.

Ben-Zvi I, Herskovizh C, Kukuy O, et al. Familial Mediterranean fever without MEFV mutations: a case-control study. Orphanet J Rare Dis, 2015; 10: 34.

Grossman C, Kassel Y, Livneh A, Ben-Zvi I. Familial Mediterranean fever (FMF) phenotype in patients homozygous to the MEFV M694V mutation. Eur J Med Genet, 2019; 62:103532.

Touitou I, Picot MC, Domingo C, Notarnicola C, Cattan D, Demaille J, et al. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum, 2001; 44: 163-169.

Stehlik C, Reed JC. The PYRIN connection: novel players in innate immunity and inflammation. J Exp Med, 2004; 200: 551-558.

Zheng Z, Li G. Mechanisms and Therapeutic Regulation of Pyroptosis in Inflammatory Diseases and Cancer. Int J Mol Sci, 2020; 21(4): 1456.

Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol, 2016; 17: 914-921.

Ben-Chetrit E. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-familial-mediterranean-fever?search

Lidar M, Yaqubov M, Zaks N, Ben-Horin S, Langevitz P, Livneh A. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol, 2006; 33: 1089-1092.

Ben-Chetrit E, Yazici H. Familial Mediterranean fever: different faces around the world. Clin Exp Rheumatol, 2019; 37 Suppl 121: 18-22.

Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, et al. Familial Mediterranean fever in children presenting with attacks of fever alone. J Rheumatol, 2010; 37: 865-869.

Lidar M, Doron A, Barzilai A, Feld O, Zaks N, Livneh A et al. Erysipelas-like erythema as the presenting feature of familial Mediterranean fever. J Eur Acad Dermatol Venereol, 2013; 27: 912-915.

Ertekin V, Selimoğlu MA, Alp H, Yilmaz N. Familial Mediterranean fever protracted febrile myalgia in children: report of two cases. Rheumatol Int, 2005; 25: 398-400.

Capron J, Grateau G, Steichen O. Is recurrent aseptic meningitis a manifestation of familial Mediterranean fever? A systematic review. Clin Exp Rheumatol, 2013; 31: 127-132.

Rigante D, Lopalco G, Tarantino G, Compagnone A, Fastiggi M, Cantarini L. Non-canonical manifestations of familial Mediterranean fever: a changing paradigm. Clin Rheumatol, 2015; 34: 1503-1511.

Cosan F, Ustek D, Oku B, Duymaz-Tozkır J, Cakiris A, Abaci N, et al. Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum, 2010; 62: 3232-3236.

Tunca M, Akar S, Onen F, Ozdoğan H, Kasapcopur O, Yalcinkaya F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore), 2005; 84: 1-11.

Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H, et al. Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology (Oxford), 2014; 53: 741-745.

Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum, 2007; 56: 1706-1712.

Berkun Y, Ben-Chetrit E, Klar A, Ben-Chetrit E. Peritoneal adhesions and intestinal obstructions in patients with familial Mediterranean fever--are they more frequent? Semin Arthritis Rheum, 2007; 36: 316-321.

Haimov-Kochman R, Ben-Chetrit E. The effect of colchicine treatment on sperm production and function: a review. Hum Reprod, 1998; 13: 360-362.

Leung YY, Yao Hui LL, Kraus VB. Colchicine--Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum, 2015; 45:341-350.

Ben-Chetrit E. https://www.uptodate.com/contents/management-of-familial-mediterranean-fever?search

Polat A, Acikel C, Sozeri B, Dursun I, Kasapcopur O, Gulez N, et al. Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever--a randomized controlled noninferiority trial. Arthritis Res Ther, 2016; 18: 85.

Saatci U, Bakkaloglu A, Ozen S, Besbas N. Familial Mediterranean fever and amyloidosis in children. Acta Paediatr, 1993; 82: 705-706.

Herscovici T, Merlob P, Stahl B, et al. Colchicine use during breastfeeding. Breastfeed Med, 2015; 10: 92-95.

Barron K, Kastner DL. Periodic fever syndromes and other inherited autoinflammatory diseases. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC (eds). Textbook of Pediatric Rheumatology.Eighth edition, Elsevier, Philadelphia, 2021: 525-543.

Ben-Chetrit E. https://www.uptodate.com/contents/familial-mediterranean-fever-epidemiology-genetics-and-pathogenesis?search

Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine, 1998; 77(4): 268-297.

Van Gorp H, Huang L, Saavedra P, Vuylsteke M, Asaoka T, Prencipe G et al. Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever. Ann Rheum Dis, 2020; 79: 960-968.

Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet, 2001; 9: 473-483.

Ben-Zvi I, Herskovizh C, Kukuy O, et al. Familial Mediterranean fever without MEFV mutations: a case-control study. Orphanet J Rare Dis, 2015; 10: 34.

Grossman C, Kassel Y, Livneh A, Ben-Zvi I. Familial Mediterranean fever (FMF) phenotype in patients homozygous to the MEFV M694V mutation. Eur J Med Genet, 2019; 62:103532.

Touitou I, Picot MC, Domingo C, Notarnicola C, Cattan D, Demaille J, et al. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum, 2001; 44: 163-169.

Stehlik C, Reed JC. The PYRIN connection: novel players in innate immunity and inflammation. J Exp Med, 2004; 200: 551-558.

Zheng Z, Li G. Mechanisms and Therapeutic Regulation of Pyroptosis in Inflammatory Diseases and Cancer. Int J Mol Sci, 2020; 21(4): 1456.

Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol, 2016; 17: 914-921.

Ben-Chetrit E. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-familial-mediterranean-fever?search

Lidar M, Yaqubov M, Zaks N, Ben-Horin S, Langevitz P, Livneh A. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol, 2006; 33: 1089-1092.

Ben-Chetrit E, Yazici H. Familial Mediterranean fever: different faces around the world. Clin Exp Rheumatol, 2019; 37 Suppl 121: 18-22.

Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, et al. Familial Mediterranean fever in children presenting with attacks of fever alone. J Rheumatol, 2010; 37: 865-869.

Lidar M, Doron A, Barzilai A, Feld O, Zaks N, Livneh A et al. Erysipelas-like erythema as the presenting feature of familial Mediterranean fever. J Eur Acad Dermatol Venereol, 2013; 27: 912-915.

Ertekin V, Selimoğlu MA, Alp H, Yilmaz N. Familial Mediterranean fever protracted febrile myalgia in children: report of two cases. Rheumatol Int, 2005; 25: 398-400.

Capron J, Grateau G, Steichen O. Is recurrent aseptic meningitis a manifestation of familial Mediterranean fever? A systematic review. Clin Exp Rheumatol, 2013; 31: 127-132.

Rigante D, Lopalco G, Tarantino G, Compagnone A, Fastiggi M, Cantarini L. Non-canonical manifestations of familial Mediterranean fever: a changing paradigm. Clin Rheumatol, 2015; 34: 1503-1511.

Cosan F, Ustek D, Oku B, Duymaz-Tozkır J, Cakiris A, Abaci N, et al. Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum, 2010; 62: 3232-3236.

Tunca M, Akar S, Onen F, Ozdoğan H, Kasapcopur O, Yalcinkaya F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore), 2005; 84: 1-11.

Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H, et al. Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology (Oxford), 2014; 53: 741-745.

Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum, 2007; 56: 1706-1712.

Berkun Y, Ben-Chetrit E, Klar A, Ben-Chetrit E. Peritoneal adhesions and intestinal obstructions in patients with familial Mediterranean fever--are they more frequent? Semin Arthritis Rheum, 2007; 36: 316-321.

Haimov-Kochman R, Ben-Chetrit E. The effect of colchicine treatment on sperm production and function: a review. Hum Reprod, 1998; 13: 360-362.

Leung YY, Yao Hui LL, Kraus VB. Colchicine--Update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum, 2015; 45:341-350.

Ben-Chetrit E. https://www.uptodate.com/contents/management-of-familial-mediterranean-fever?search

Polat A, Acikel C, Sozeri B, Dursun I, Kasapcopur O, Gulez N, et al. Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever--a randomized controlled noninferiority trial. Arthritis Res Ther, 2016; 18: 85.

Saatci U, Bakkaloglu A, Ozen S, Besbas N. Familial Mediterranean fever and amyloidosis in children. Acta Paediatr, 1993; 82: 705-706.

Herscovici T, Merlob P, Stahl B, et al. Colchicine use during breastfeeding. Breastfeed Med, 2015; 10: 92-95.